These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11379713)

  • 1. A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting.
    Katz KC; Gardam MA; Burt J; Conly JM
    Infect Control Hosp Epidemiol; 2001 Apr; 22(4):219-21. PubMed ID: 11379713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
    Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program.
    Hacek DM; Bednarz P; Noskin GA; Zembower T; Peterson LR
    J Clin Microbiol; 2001 Mar; 39(3):1152-4. PubMed ID: 11230446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model.
    Lee TA; Hacek DM; Stroupe KT; Collins SM; Peterson LR
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):39-46. PubMed ID: 15693407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests.
    Depitre C; Avesani V; Delmée M; Corthier G
    Gastroenterol Clin Biol; 1993; 17(4):283-6. PubMed ID: 8339887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Fujitani S; George WL; Morgan MA; Nichols S; Murthy AR
    Am J Infect Control; 2011 Apr; 39(3):188-93. PubMed ID: 21458682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for vancomycin-resistant enterococci using stools sent for Clostridium difficile cytotoxin assay is effective: results of a survey of 300 Patients in a large Singapore Teaching Hospital.
    Tay JK; Bodle EE; Fisher DA; Lin RV; Kumarasinghe G; Tambyah PA
    Ann Acad Med Singap; 2007 Nov; 36(11):926-9. PubMed ID: 18071603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.
    Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D;
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
    Miller M; Bernard L; Thompson M; Grima D; Pepin J
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.
    Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC
    Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy.
    Ray AJ; Hoyen CK; Das SM; Eckstein EC; Donskey CJ
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):474-7. PubMed ID: 12186217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance.
    Poduval RD; Kamath RP; Corpuz M; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2000 Dec; 95(12):3513-5. PubMed ID: 11151886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infections in a tertiary hospital: value of surveillance.
    Lekalakala MR; Lewis E; Hoosen AA
    J Hosp Infect; 2010 Aug; 75(4):328-9. PubMed ID: 20542596
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypervirulent Clostridium difficile Strain Has Arrived in Brazil.
    Pires RN; Monteiro AA; Saldanha GZ; Falci DR; Caurio CFB; Sukiennik TCT; Adam FC; Pasqualotto AC; Martins AF
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):371-373. PubMed ID: 29368667
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease.
    Debast SB; van Kregten E; Oskam KM; van den Berg T; Van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2008 Jun; 14(6):622-4. PubMed ID: 18393996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.
    Hwang JH; Park JS; Lee E; Bae JY; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh M; Kim HB
    J Hosp Infect; 2018 Aug; 99(4):487-491. PubMed ID: 29476883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which specimens should be tested for Clostridium difficile toxin?
    Berrington A; Settle CD
    J Hosp Infect; 2007 Mar; 65(3):280-2. PubMed ID: 17275962
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.
    Lucet JC; Armand-Lefevre L; Laurichesse JJ; Macrez A; Papy E; Ruimy R; Deblangy C; Lozach A; Lolom I; Jarlier V; Andremont A; Leport C
    J Hosp Infect; 2007 Sep; 67(1):42-8. PubMed ID: 17719129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Clostridium perfringens enterotoxin and Clostridium difficile toxin A in feces of horses with diarrhea and colic.
    Donaldson MT; Palmer JE
    J Am Vet Med Assoc; 1999 Aug; 215(3):358-61. PubMed ID: 10434974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.